Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Debt to Equity Ratio : -2.452 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.452 |
| March 31, 2026 | -2.751 |
| December 31, 2025 | -2.283 |
| September 30, 2025 | -2.265 |
| June 30, 2025 | -1.943 |
| March 31, 2025 | -1.793 |
| December 31, 2024 | -1.989 |
| September 30, 2024 | -1.975 |
| June 30, 2024 | -1.990 |
| March 31, 2024 | -2.089 |
| December 31, 2023 | -2.066 |
| September 30, 2023 | -2.292 |
| June 30, 2023 | -2.360 |
| March 31, 2023 | 0.5883 |
| December 31, 2022 | 0.6375 |
| September 30, 2022 | 0.7038 |
| June 30, 2022 | 0.7808 |
| March 31, 2022 | 1.037 |
| December 31, 2021 | 0.7853 |
| September 30, 2021 | 0.8107 |
| June 30, 2021 | 0.9078 |
| March 31, 2021 | 4.166 |
| December 31, 2020 | 7.243 |
| September 30, 2020 | 75.95 |
| June 30, 2020 | -12.01 |
| Date | Value |
|---|---|
| March 31, 2020 | -6.106 |
| December 31, 2019 | -4.624 |
| September 30, 2019 | -2.844 |
| June 30, 2019 | -1.970 |
| March 31, 2019 | -2.10 |
| December 31, 2018 | -2.108 |
| September 30, 2018 | -2.075 |
| June 30, 2018 | -9.264 |
| March 31, 2018 | -22.36 |
| December 31, 2017 | 40.63 |
| September 30, 2017 | -22.55 |
| June 30, 2017 | 80.69 |
| March 31, 2017 | 13.14 |
| December 31, 2016 | 5.588 |
| September 30, 2016 | 6.302 |
| June 30, 2016 | 4.634 |
| March 31, 2016 | 4.174 |
| December 31, 2015 | 4.010 |
| September 30, 2015 | 4.436 |
| June 30, 2015 | 3.224 |
| March 31, 2015 | 2.565 |
| December 31, 2014 | 2.002 |
| September 30, 2014 | 1.653 |
| June 30, 2014 | 1.262 |
| March 31, 2014 | 0.9457 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Rigel Pharmaceuticals, Inc. | 0.0939 |
| Marker Therapeutics, Inc. | 0.00 |
| Verastem, Inc. | 1.687 |
| Theriva Biologics, Inc. | 0.2915 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 285.13M |
| Total Liabilities (Quarterly) | 446.97M |
| Shareholders Equity (Quarterly) | -161.84M |
| Current Ratio | 6.063 |
| Net Debt Paydown Yield | 5.81% |